Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Fumiko Katsushima is active.

Publication


Featured researches published by Fumiko Katsushima.


Hepatology Research | 2014

Expression of micro-RNAs in peripheral blood mononuclear cells from primary biliary cirrhosis patients

Fumiko Katsushima; Atsushi Takahashi; Natsumi Sakamoto; Yukiko Kanno; Kazumichi Abe; Hiromasa Ohira

The aim of this study was to clarify the relationship between the expression of micro‐RNAs (miRNAs) in peripheral blood mononuclear cells (PBMCs) and clinical presentation in patients with primary biliary cirrhosis (PBC).


World Journal of Hepatology | 2012

Centrilobular necrosis in acute presentation of Japanese patients with type 1 autoimmune hepatitis

Kazumichi Abe; Yukiko Kanno; Ken Okai; Fumiko Katsushima; Kyoko Monoe; Hironobu Saito; Atsushi Takahashi; Junko Yokokawa; Hiromasa Ohira

AIM To compare clinicopathological features of acute presentation of type 1 autoimmune hepatitis (AIH) with or without centrilobular necrosis (CN). METHODS Our study comprised 41 patients with biopsy-proven acute presentation (acute exacerbation phase 36, acute hepatitis phase 5) of type 1 AIH at our hospital from 1975 to 2009. Elevated serum alanine aminotransferase (ALT) (> 5x upper limit of normal) identified acute presentation of the disease. We compared clinicopathological features of these AIH patients with or without CN. The data used for analysis included patient background (age, sex, type of disease, presence of complications with other autoimmune diseases, human leukocyte antigen, and International Autoimmune Hepatitis Group score), clinical parameters at presentation (ALT, alkaline phosphatase, IgG, anti-nuclear antibodies, and anti-smooth muscle antibodies), histology and therapy. RESULTS CN was found in 13 (31.7%) patients with acute presentation (acute exacerbation phase 10, acute hepatitis phase 3) of AIH. Serum IgG levels of patients with CN were significantly lower than those of patients without CN (mean: 2307 mg/dL vs 3126 mg/dL, P < 0.05), while antinuclear antibody-negative rates were significantly higher (30.7% vs 3.5%, P < 0.05). However, other clinical features were similar between the two groups. The frequency of advanced fibrosis in patients with CN was significantly lower than in patients without CN (F0-2: 84.6% vs 35.7%, F3-4: 15.4% vs 64.3%, P < 0.05). Other histological features were similar between the two groups. Although there was no significant difference between groups when evaluated using the revised original score (12 vs 14), the simplified AIH score of patients with CN was significantly lower (6 vs 7, P < 0.05). Frequency of DR4 was similar between patients with and without CN. CONCLUSION CN is observed in both Japanese patients with acute hepatitis phase and acute exacerbation phase of type 1 AIH, although AIH with CN often shows clinical features of the genuine acute form.


Hepatology Research | 2014

Anti‐nucleosome autoantibodies as markers for autoimmune hepatitis and their correlation with disease activity

Junko Yokokawa; Yukiko Kanno; Kazumichi Abe; Hironobu Saito; Kyoko Monoe; Fumiko Katsushima; Natsumi Sakamoto; Atsushi Takahashi; Hirohide Yokokawa; Hiromasa Ohira

To assess the prevalence of autoantibodies against nucleosomes (anti‐nucleosome Ab) in patients with autoimmune hepatitis (AIH), examine the correlation between anti‐nucleosome Ab and disease activity, and evaluate the effectiveness of anti‐nucleosome Ab in predicting relapse.


Hepatology Research | 2013

Case of idiopathic portal hypertension complicated with autoimmune hepatitis

Kazumichi Abe; Atsushi Takahashi; Yu Sato; Ken Okai; Fumiko Katsushima; Kyoko Monoe; Yukiko Kanno; Hironobu Saito; Hiromasa Ohira

We report a case of idiopathic portal hypertension (IPH) complicated with autoimmune hepatitis. A 60‐year‐old woman was admitted to our hospital with esophageal and gastric varices in February 2010. Abdominal ultrasonography and computed tomography showed splenomegaly and collateral veins without evidence of liver cirrhosis. Laboratory examinations and liver biopsy indicated that the esophageal and gastric varices were caused by IPH. She underwent endoscopic injection sclerotherapy and partial splenic embolization. Two years after these therapies, laboratory examinations showed liver dysfunction with elevated levels of aspartate aminotransferase (180 IU/L), alanine aminotransferase (190 IU/L), γ‐glutamyl transpeptidase (159 IU/L) and immunoglobulin G (2609 mg/dL). The titer of antinuclear antibodies was 1:320 and its pattern was homogeneous and speckled. Histological examination revealed plasma cell/lymphocyte infiltration and interface hepatitis in the portal tract. Based on these findings, a diagnosis of autoimmune hepatitis accompanied by IPH was made. After treatment with prednisolone (20 mg/day), liver functions were normalized immediately. Overlapping of IPH and AIH is extremely rare, but the present case is interesting considering the etiology of IPH because an autoimmune mechanism is thought to be involved in the pathogenesis of IPH.


Internal Medicine | 2013

Liver Dysfunction in Patients with Systemic Lupus Erythematosus

Atsushi Takahashi; Kazumichi Abe; Rie Saito; Haruyo Iwadate; Ken Okai; Fumiko Katsushima; Kyoko Monoe; Yukiko Kanno; Hironobu Saito; Hiroko Kobayashi; Hiroshi Watanabe; Hiromasa Ohira


Fukushima journal of medical science | 2012

Autoantibodies by line immunoassay in patients with primary biliary cirrhosis.

Hironobu Saito; Atsushi Takahashi; Kazumichi Abe; Ken Okai; Fumiko Katsushima; Kyoko Monoe; Yukiko Kanno; Hiromasa Ohira


Internal Medicine | 2012

Clinical Features of Cirrhosis in Japanese Patients with Type I Autoimmune Hepatitis

Kazumichi Abe; Fumiko Katsushima; Yukiko Kanno; Atsushi Takahashi; Junko Yokokawa; Hiromasa Ohira; Teruko Arinaga; Tatsuya Ide; Junko Nishimura; Megumi Inoue; Masataka Seike; Fumio Imazeki; Osamu Yokosuka; Michio Sata


World Journal of Gastroenterology | 2009

A case of advanced intrahepatic cholangiocarcinoma successfully treated with chemosensitivity test-guided systemic chemotherapy

Kazumichi Abe; Takeru Wakatsuki; Fumiko Katsushima; Kyoko Monoe; Yukiko Kanno; Atsushi Takahashi; Junko Yokokawa; Hiromasa Ohira


Kanzo | 2009

Re-analysis of patients with autoimmune hepatitis using simplified diagnostic criteria

Fumiko Katsushima; Kazumichi Abe; Junko Yokokawa; Kyoko Monoe; Yukiko Kanno; Atsushi Takahashi; Hiromasa Ohira


Clinical Journal of Gastroenterology | 2012

A case of peripheral T-cell lymphoma presenting with acute liver failure

Naoki Konno; Atsushi Takahashi; Kenya Watanabe; Fumiko Katsushima; Kyoko Monoe; Yukiko Kanno; Hironobu Saito; Kazumichi Abe; Hiromasa Ohira

Collaboration


Dive into the Fumiko Katsushima's collaboration.

Top Co-Authors

Avatar

Hiromasa Ohira

Fukushima Medical University

View shared research outputs
Top Co-Authors

Avatar

Atsushi Takahashi

Fukushima Medical University

View shared research outputs
Top Co-Authors

Avatar

Kazumichi Abe

Fukushima Medical University

View shared research outputs
Top Co-Authors

Avatar

Yukiko Kanno

Fukushima Medical University

View shared research outputs
Top Co-Authors

Avatar

Kyoko Monoe

Fukushima Medical University

View shared research outputs
Top Co-Authors

Avatar

Hironobu Saito

Fukushima Medical University

View shared research outputs
Top Co-Authors

Avatar

Junko Yokokawa

Fukushima Medical University

View shared research outputs
Top Co-Authors

Avatar

Ken Okai

Fukushima Medical University

View shared research outputs
Top Co-Authors

Avatar

Haruyo Iwadate

Fukushima Medical University

View shared research outputs
Top Co-Authors

Avatar

Hiroko Kobayashi

Fukushima Medical University

View shared research outputs
Researchain Logo
Decentralizing Knowledge